Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where B.T. Collins is active.

Publication


Featured researches published by B.T. Collins.


Cancer | 2007

Cyberknife radiosurgery for breast cancer spine metastases : A matched-pair analysis

Gregory J. Gagnon; Fraser C. Henderson; Edmund A. Gehan; Donna Sanford; B.T. Collins; Jefferson Moulds; Anatoly Dritschilo

There are few options for breast cancer patients with spinal metastases recurrent within a previous radiation treatment field. CyberKnife radiosurgery has been used in our institution to treat such patients. To evaluate their outcomes, as there are no comparable radiation treatment options, the outcomes were compared between 18 patients with spinal metastases from breast cancer treated with CyberKnife stereotactic radiosurgery, 17 of which had prior radiotherapy to the involved spinal region and were progressing, and 18 matched patients who received conventional external beam radiotherapy (CRT) up‐front for spinal metastases.


Radiation Oncology | 2014

Proctitis following stereotactic body radiation therapy for prostate cancer.

Daniel Y Joh; Leonard N. Chen; Gerald Porter; Aditi Bhagat; Sumit Sood; Joy S Kim; Rudy Moures; Thomas M. Yung; Siyuan Lei; B.T. Collins; Andrew Ju; Simeng Suy; John Carroll; John H. Lynch; Anatoly Dritschilo; Sean P. Collins

BackgroundProctitis after radiation therapy for prostate cancer remains an ongoing clinical challenge and critical quality of life issue. SBRT could minimize rectal toxicity by reducing the volume of rectum receiving high radiation doses and offers the potential radiobiologic benefits of hypofractionation. This study sought to evaluate the incidence and severity of proctitis following SBRT for prostate cancer.MethodsBetween February 2008 and July 2011, 269 men with clinically localized prostate cancer were treated definitively with SBRT monotherapy at Georgetown University Hospital. All patients were treated to 35-36.25Gy in 5 fractions delivered with the CyberKnife Radiosurgical System (Accuray). Rectal bleeding was recorded and scored using the CTCAE v.4. Telangiectasias were graded using the Vienna Rectoscopy Score (VRS). Proctitis was assessed via the Bowel domain of the Expanded Prostate Index Composite (EPIC)-26 at baseline and at 1, 3, 6, 9, 12, 18 and 24xa0months post-SBRT.ResultsThe median age was 69 years with a median prostate volume of 39 cc. The median follow-up was 3.9 years with a minimum follow-up of two years. The 2-year actuarial incidence of late rectal bleeding ≥ grade 2 was 1.5%. Endoscopy revealed VRS Grade 2 rectal telangiectasias in 11% of patients. All proctitis symptoms increased at one month post-SBRT but returned to near-baseline with longer follow-up. The most bothersome symptoms were bowel urgency and frequency. At one month post-SBRT, 11.2% and 8.5% of patients reported a moderate to big problem with bowel urgency and frequency, respectively. The EPIC bowel summary scores declined transiently at 1 month and experienced a second, more protracted decline between 6 months and 18 months before returning to near-baseline at two years post-SBRT. Prior to treatment, 4.1% of men felt their bowel function was a moderate to big problem which increased to 11.5% one month post-SBRT but returned to near-baseline at two years post-SBRT.ConclusionsIn this single institution cohort, the rate and severity of proctitis observed following SBRT is low. QOL decreased on follow-up; however, our results compare favorably to those reported for patients treated with alternative radiation modalities. Future prospective randomized studies are needed to confirm these observations.


Frontiers in Oncology | 2016

The Value of the History and Physical for Patients with Newly Diagnosed Brain Metastases Considering Radiosurgery.

Ima Paydar; Eric Karl Oermann; Miriam Knoll; James Lee; B.T. Collins; Matthew G. Ewend; Douglas Kondziolka; Sean P. Collins

Background For patients with brain metastases, systemic disease burden has historically been accepted as a major determinant of overall survival (OS). However, less research has focused on specific history and physical findings made by clinicians and how such findings pertain to patient outcomes at a given time point. The aim of this study is to determine how the initial clinical assessment of patients with brain metastases, as part of the history and physical at the time of consultation, correlates to patient prognosis. Methods We evaluated a prospective, multi-institutional database of 1523 brain metastases in 507 patients who were treated with radiosurgery (Gamma Knife or CyberKnife) from 2001 to 2014. Relevant history of present illness (HPI) and past medical history (PMH) variables included comorbidities, Eastern Cooperative Oncology Group (ECOG) performance status, and seizure history. Physical exam findings included a sensory exam, motor exam, and cognitive function. Univariate and multivariate Cox regression analyses were used to identify predictors of OS. Results Two hundred ninety-four patients were included in the final analysis with a median OS of 10.8u2009months (95% CI, 7.8–13.7u2009months). On univariate analysis, significant HPI predictors of OS included age, primary diagnosis, performance status, extracranial metastases, systemic disease status, and history of surgery. Significant predictors of OS from the PMH included cardiac, vascular, and infectious comorbidities. On a physical exam, findings consistent with cognitive deficits were predictive of worse OS. However, motor deficits or changes in vision were not predictive of worse OS. In the multivariate Cox regression analysis, predictors of worse OS were primary diagnosis (pu2009=u20090.002), ECOG performance status (OR 1.73, pu2009<u20090.001), and presence of extracranial metastases (OR 1.22, pu2009=u20090.009). Conclusion Neurological deficits and systemic comorbidities noted at presentation are not associated with worse overall prognosis for patients with brain metastases undergoing radiosurgery. When encountering new patients with brain metastases, the most informative patient-related characteristics that determine prognosis remain performance status, primary diagnosis, and extent of extracranial disease.


International Journal of Radiation Oncology Biology Physics | 2017

Poster ViewingStereotactic Body Radiation Therapy (SBRT) for Prostate Cancer in Men with a High International Prostate Symptom Score (IPSS > 15)

S. Kataria; J. Chew; S. Lei; M.J. Ayoob; M. Danner; Thomas M. Yung; B.T. Collins; S. Suy; Anatoly Dritschilo; John H. Lynch; Sean P. Collins


International Journal of Radiation Oncology Biology Physics | 2015

Definitive Radiation Therapy for Early-Stage Breast Cancer: Dosimetric Feasibility of Stereotactic Ablative Radiosurgery (SABR) for Intact Breast Tumors

J.W. Lischalk; O. Obayomi-Davies; Thomas P. Kole; L. Campbell; S. Rudra; Sean P. Collins; B.T. Collins


International Journal of Radiation Oncology Biology Physics | 2018

Reduced PSA Surveillance Following SBRT for Favorable Prostate Cancer Decreases the Incidence of Anxiety-Promoting Benign PSA Bounces without Limiting the Early Detection of Biochemical Failures

Nima Aghdam; C.P. Smith; M. Danner; M.J. Ayoob; Thomas M. Yung; S. Lei; B.T. Collins; Jonathan W. Lischalk; Anatoly Dritschilo; S. Suy; Sean P. Collins


International Journal of Radiation Oncology Biology Physics | 2017

Poster ViewingPredictors of Decreased Mobility Following Stereotactic Body Radiation Therapy for Prostate Cancer

Nima Aghdam; C.P. Smith; C. D. Johnson; M. Danner; M.J. Ayoob; Thomas M. Yung; S. Lei; B.T. Collins; Anatoly Dritschilo; S. Suy; John H. Lynch; Sean P. Collins


International Journal of Radiation Oncology Biology Physics | 2017

Utilization of Patient-Reported Outcomes to Guide Symptom Management During Stereotactic Body Radiation Therapy for Prostate Cancer

Sean P. Collins; M. Danner; M.Y. Hung; M.J. Ayoob; Thomas M. Yung; S. Lei; B.T. Collins; Anatoly Dritschilo; S. Suy


International Journal of Radiation Oncology Biology Physics | 2015

Number of Brain Metastases Treated With Radiosurgery Is Not Associated With Long-term Survival

M.A. Knoll; E. Oermann; Andrew I. Yang; S. Green; B.T. Collins; Sean P. Collins; Matthew G. Ewend; Douglas Kondziolka


International Journal of Radiation Oncology Biology Physics | 2015

Initial Neurologic Examination Does Not Determine Survival in Patients With Brain Metastases

E. Oermann; M.A. Knoll; Andrew I. Yang; B.T. Collins; Sean P. Collins; Matthew G. Ewend; Douglas Kondziolka

Collaboration


Dive into the B.T. Collins's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

S. Suy

MedStar Georgetown University Hospital

View shared research outputs
Top Co-Authors

Avatar

S. Lei

Georgetown University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Matthew G. Ewend

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge